Related Experiment Video
Updated: Apr 14, 2026

09:57
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
Published on: June 4, 2017
12.9K
Radiation therapy for glioma stem cells.
Anthony E Rizzo1, Jennifer S Yu
1Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA, rizzoa4@ccf.org.
Advances in Experimental Medicine and Biology
|April 22, 2015
Summary
Radiation therapy improves survival for high-grade glioma patients. However, cancer stem cells resist treatment, contributing to recurrence, necessitating new therapeutic strategies.
Area of Science:
- Oncology
- Radiation Oncology
- Cancer Biology
Background:
- Radiation therapy is a cornerstone adjuvant treatment for high-grade gliomas, significantly improving patient survival.
- Cancer stem cells (CSCs) are increasingly recognized for their role in tumor biology, resistance, and recurrence.
- CSCs possess intrinsic mechanisms to survive radiation and are supported by the tumor microenvironment.
Purpose of the Study:
- To review the current use of radiation therapy for high-grade gliomas.
- To examine the role of therapeutically resistant cancer stem cells in glioma radioresistance.
- To discuss strategies for improving radiosensitivity and identify new therapeutic targets.
Main Methods:
- Literature review of radiation therapy in high-grade gliomas.
- Analysis of cancer stem cell biology and radioresistance mechanisms.
- Discussion of clinical efforts and novel targets for enhancing radiosensitivity.
Main Results:
- Radiation therapy remains highly effective for high-grade gliomas.
- Cancer stem cells exhibit resistance to radiation, contributing to disease recurrence.
- The tumor microenvironment supports glioma stem cell maintenance and proliferation.
Conclusions:
- Understanding cancer stem cell radioresistance is crucial for optimizing glioma treatment.
- Current clinical efforts focus on improving radiosensitivity through various strategies.
- Further research into novel targets is needed to overcome therapeutic resistance in high-grade gliomas.

